HSCS

HeartSciences Inc. (HSCS) | Rumor.io

HeartSciences

HSCS

Attention (50-day avg)0%

Attention rank (50-day avg)#2,503

Bullish sentiment (50-day avg)93%

Price to earnings ratio0.55

Market capitalization21.3M

Earnings per share-2.76

Dividend yield (TTM)—

Revenue (annual)4.3K

Net income (annual)-9.1M

Social

What share of all stock conversation is about HSCS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% 0

Jun 25

$HSCS has shown a strong momentum and sentiment-driven spike, breaking out above 2.60 resistance, with a 13.31% price increase.
The stock has a high cost to borrow rate of 327%, indicating significant short-term speculative flow.
$HSCS has demonstrated potential for growth, with some traders predicting it to reclaim $3.10 and achieve multiple price targets.

Generated by AI

Sentiment

Of the messages about HSCS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% 0	100% 0	94.23% +10.9	86.74% +10.42
Bearish	0% 0	0% 0	5.77% -10.9	13.26% -10.42

Bullish· Jun 23

$HSCS has seen significant trading volume, with 18M shares traded, indicating strong market interest.
The company has expanded its ATM program, allowing it to sell up to $25M of stock, and has already used this program during FY2026.
$HSCS has broken out, with a 50.3% increase in price on 118,019,119 volume, and is showing strong upward momentum.

Bearish· Jun 23

The bid for $HSCS has been unusually low in volume, potentially indicating a lack of interest in the stock.
The merger between HeartSciences and Fortitude may lead to significant dilution of existing shares.
The company's involvement in the cryptocurrency space may be a red flag, with one post suggesting it's a "scam" and another indicating a failed merger.

Generated by AI

Topics

Of the messages about HSCS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	95.45%	84.29%	75.7%
Technical Analysis	100%	4.55%	7.14%	14.19%
Analysts	0%	0%	8.57%	6.74%
Controversies	0%	0%	0%	0.42%
Earnings	0%	0%	0%	0.42%
Macro	0%	0%	0%	2.53%

Announcements· Jun 23

HeartSciences ($HSCS) is merging with Fortitude Mining Holdings in the second half of 2026, with the combined entity to operate as Fortitude and trade on Nasdaq under the ticker $TUDE.
The merged company will be a vertically-integrated Zcash mining platform, leveraging scale, Digital Currency Group (DCG) backing, and operational discipline for growth.
Existing HeartSciences holders will own just 5% of the combined entity, with DCG owning 95% post-close, resulting in significant dilution for HSCS shareholders.

Technical Analysis· Jun 23

$HSCS has a key level rejection at the higher resistance level, with two separate key level failures.
The stock has a considerable cushion and is on the watchlist, with potential for a breakout to $3.25 (+15%).
$HSCS is rotating within $2.65–$2.85, with repeated acceptance back above the mid-zone and rejection at the highs, suggesting a clear structure.

Generated by AI

Community

Of the messages about HSCS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	20%	27.78%	25.35%	36.72%
Newcomers	80%	72.22%	74.65%	63.28%

Regulars· Sep 24

Ascendiant Capital has given Heart Test Laboratories, Inc. ($HSCS) a $15.00 price target, potentially influencing sentiment.
The stock's potential breakout play setup involves identifying the high of the after-hours session, drawing a line, and then observing a pullback and creep before breaking through the line.
The regulars are advising to be cautious and manage risks, looking for where volume flows in or where stocks respect support areas, rather than rushing into a trade.

Newcomers· Jun 23

*Newcomers to $HSCS are focused on its potential as a medical technology company, with some questioning whether the company's shift towards crypto mining will affect its valuation.*
*The recent surge in $HSCS is attributed to the company's launch of MyoVista Insights 1.3 with an AI-ECG algorithm marketplace, which has helped detect various heart conditions.*
*Investors are monitoring $HSCS's price movement, with some noting that the stock's small float and high volume are good signs, but others are concerned about the potential for extreme dilution due to the company's definitive merger agreement with Fortitude Mining Holdings.*

Generated by AI

News

HeartSciences' Merger Partner Fortitude Upsizes DCG Credit Facility to $50 Million

HeartSciences (HSCS) proposed merger partner Fortitude Mining has amended its existing credit facili

6d agoYahoo Finance

HeartSciences to Merge with Fortitude Mining, Rebrand

Detailed price information for Heartsciences Inc (HSCS-Q) from The Globe and Mail including charting and trades.

12d agoThe Globe and Mail

HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates

HeartSciences Inc. (HSCS) delivered earnings and revenue surprises of -10.26% and -97.90%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

15d agoYahoo Finance

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

1mo agoBarchart.com

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company’s shareholders...

2mo agoBarchart.com

Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio

Fortitude Mining Holdings, Inc., a vertically-integrated digital asset mining platform anchored in Zcash, today announced the energization of its new facility in Grand Island, Nebraska. The energization follows Fortitude’ s previous announcement that it has entered into a definitive agreement for a business combination transaction with HeartSciences...

2mo agoNasdaq

Also Discussed

Investors talking about HSCS also mention

#	Name	Attention
1	Cardio Diagnostics Holdings, Inc.CDIO	0%0
2	TCBP - TC Biopharm (Holdings) Plc	——
3	LMDX - LumiraDx Limited	——
4	Avenue Therapeutics Inc.ATXI	0%new
5	Getaround, Inc.GETR	0%new
6	KLG - WK Kellogg Co	——
7	CNXA - Connexa Sports Technologies Inc.	——
8	CYTO - Altamira Therapeutics Ltd.	——
9	United Maritime CorporationUSEA	0%0
10	Intelligent Bio Solutions Inc.INBS	0%0

HeartSciences Inc.

Healthcare
Medical Devices

HeartSciences Inc. is a medical technology company focused on artificial intelligence-enhanced electrocardiography. The company develops AI-ECG solutions designed to improve the clinical usefulness of standard ECG testing by helping detect cardiac dysfunction and related heart conditions earlier in care pathways. Its current product set includes the MyoVista wavECG device, a resting 12-lead ECG that combines conventional rhythm and diagnostic information in a single test, and MyoVista Insights, a cloud-native ECG management platform that is designed to work across different device and vendor environments. HeartSciences serves healthcare settings where rapid cardiac screening and interpretation are important, including frontline and point-of-care environments. Founded in 2007 and headquartered in Southlake, Texas, the company positions itself within the healthcare information technology and medical devices market, with a focus on practical ECG enhancement rather than replacing existing clinical workflows.

Website

Location

550 Reserve Street

Southlake, TX, 76092

United States

Social

What share of all stock conversation is about HSCS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% 0

Jun 25

$HSCS has shown a strong momentum and sentiment-driven spike, breaking out above 2.60 resistance, with a 13.31% price increase.
The stock has a high cost to borrow rate of 327%, indicating significant short-term speculative flow.
$HSCS has demonstrated potential for growth, with some traders predicting it to reclaim $3.10 and achieve multiple price targets.

Generated by AI

Sentiment

Of the messages about HSCS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% 0	100% 0	94.23% +10.9	86.74% +10.42
Bearish	0% 0	0% 0	5.77% -10.9	13.26% -10.42

Bullish· Jun 23

$HSCS has seen significant trading volume, with 18M shares traded, indicating strong market interest.
The company has expanded its ATM program, allowing it to sell up to $25M of stock, and has already used this program during FY2026.
$HSCS has broken out, with a 50.3% increase in price on 118,019,119 volume, and is showing strong upward momentum.

Bearish· Jun 23

The bid for $HSCS has been unusually low in volume, potentially indicating a lack of interest in the stock.
The merger between HeartSciences and Fortitude may lead to significant dilution of existing shares.
The company's involvement in the cryptocurrency space may be a red flag, with one post suggesting it's a "scam" and another indicating a failed merger.

Generated by AI

Topics

Of the messages about HSCS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	95.45%	84.29%	75.7%
Technical Analysis	100%	4.55%	7.14%	14.19%
Analysts	0%	0%	8.57%	6.74%
Controversies	0%	0%	0%	0.42%
Earnings	0%	0%	0%	0.42%
Macro	0%	0%	0%	2.53%

Announcements· Jun 23

HeartSciences ($HSCS) is merging with Fortitude Mining Holdings in the second half of 2026, with the combined entity to operate as Fortitude and trade on Nasdaq under the ticker $TUDE.
The merged company will be a vertically-integrated Zcash mining platform, leveraging scale, Digital Currency Group (DCG) backing, and operational discipline for growth.
Existing HeartSciences holders will own just 5% of the combined entity, with DCG owning 95% post-close, resulting in significant dilution for HSCS shareholders.

Technical Analysis· Jun 23

$HSCS has a key level rejection at the higher resistance level, with two separate key level failures.
The stock has a considerable cushion and is on the watchlist, with potential for a breakout to $3.25 (+15%).
$HSCS is rotating within $2.65–$2.85, with repeated acceptance back above the mid-zone and rejection at the highs, suggesting a clear structure.

Generated by AI

Community

Of the messages about HSCS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	20%	27.78%	25.35%	36.72%
Newcomers	80%	72.22%	74.65%	63.28%

Regulars· Sep 24

Ascendiant Capital has given Heart Test Laboratories, Inc. ($HSCS) a $15.00 price target, potentially influencing sentiment.
The stock's potential breakout play setup involves identifying the high of the after-hours session, drawing a line, and then observing a pullback and creep before breaking through the line.
The regulars are advising to be cautious and manage risks, looking for where volume flows in or where stocks respect support areas, rather than rushing into a trade.

Newcomers· Jun 23

*Newcomers to $HSCS are focused on its potential as a medical technology company, with some questioning whether the company's shift towards crypto mining will affect its valuation.*
*The recent surge in $HSCS is attributed to the company's launch of MyoVista Insights 1.3 with an AI-ECG algorithm marketplace, which has helped detect various heart conditions.*
*Investors are monitoring $HSCS's price movement, with some noting that the stock's small float and high volume are good signs, but others are concerned about the potential for extreme dilution due to the company's definitive merger agreement with Fortitude Mining Holdings.*

Generated by AI

HeartSciences

Social

Jun 25

Bullish· Jun 23

Bearish· Jun 23

Announcements· Jun 23

Technical Analysis· Jun 23

Regulars· Sep 24

Newcomers· Jun 23

HeartSciences' Merger Partner Fortitude Upsizes DCG Credit Facility to $50 Million

HeartSciences to Merge with Fortitude Mining, Rebrand

HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio

Also Discussed

HeartSciences Inc.

Company Information

Location

HeartSciences' Merger Partner Fortitude Upsizes DCG Credit Facility to $50 Million

HeartSciences to Merge with Fortitude Mining, Rebrand

HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio

Also Discussed

Social

Jun 25

Bullish· Jun 23

Bearish· Jun 23

Announcements· Jun 23

Technical Analysis· Jun 23

Regulars· Sep 24

Newcomers· Jun 23